Nanotechnology has shown an important potential in the immunotherapeutic field, as the modulation of a variety of immune processes can be achieved both in vitro and in vivo. Nanotechnology can be used to promote the immune activation or to induce tolerance depending on the ...Learn More

The civil rights attorney, blogger, and mother to two young children, Beth Caldwell was diagnosed with breast cancer at age 37 (STAT, 2017).“There is such a culture of positivity around breast cancer,” she said. “People ask me when I will be done with treatment and I tell ...Learn More

Antibody drug conjugates (ADCs) for cancer treatments refer to a relatively new type of cancer immunotherapy that applies monoclonal antibodies to locate specific malignant cells and meanwhile relies on chemotherapeutic drugs to destroy them. In an ADC, the antibody and the drug ...Learn More

Antibody-based therapies are not new, as the use of these molecules to combat human diseases dates back to the 1890s. Antibodies are a key component of the immune system adaptive branch that recognizes a foreign molecule called antigen and mobilize various immune processes to ...Learn More

The reason why chemotherapy is so effective at eliminating cancer cells is because it focuses on all cells. What if we could target chemotherapy to cancer cells and spare the healthy cells? Scientists are developing a highly targeted medicine with this exact mechanism – called ...Learn More